November 2026 • PharmaTimes Magazine • 4-5
6. TREATMENTS
7. COLLABORATIONS
8. CLINICAL TRIALS
9. CONDITIONS
10.Burnham ambition
Fifth member of The Smiths attempts to write a compelling chorus
13.Supporting heart patients
For Alice, support was needed long after she left the consultation room
20.Sharp focus
Monitoring AI medical devices followingmarket authorisation
26.Bot now?
Explaining AI’s reasoning cannot be aproxy for safety in governance
30.Yes brainer
Getting rare disease drugs past thebrain’s self-defence mechanism
14.The great escape
Diabetes technology has transformed.Now access must catch up
17.Every drop counts
Laboratory strategies are transformingpaediatric clinical trials
24.AI together now
Four realities reshaping HCP engagement strategies
28.Game changing
Pharmacies can stand out in the TikTokShop supplements market
34.Americana!
Dreams are woven as our awards maketheir mark across the pond
18.Basic instinct
Should pharma communicators stop trying to make science ‘simple’?
22.Channelling discovery
Jelena Mann is Professor of Epigeneticsat Newcastle University
33.Good times!
Competitions corner – finals, deadlines & what’s coming up
36.Going, going...
Gone! But then reappearing somewhereelse to do something interesting
38.The data day
Where trustworthy evidence begins inthe AI ecosystem